Development

Cheaper R&D makes vaccines for neglected killers economically viable

development2026-03-18

Claim

India-based PopVax argues its generative AI, mRNA platforms and tenfold cheaper research costs can make vaccines against neglected killers like hepatitis C, tuberculosis and Strep A economically viable for the first time.

Reported metric: 10x cheaper

Reporting date: 2026-03-18 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to March 18, 2026 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to March 18, 2026

Actor

PopVax

Evidence for

Referenced by

Welcome to March 18, 2026

Cite or correct this record

Citation formatCitation text

Cheaper R&D makes vaccines for neglected killers economically viable
Innermost Loop KB — secondary record
Reporting date: 2026-03-18
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-03-18-cheaper-rd-makes-neglected-vaccines-viable
Claim: India-based PopVax argues its generative AI, mRNA platforms and tenfold cheaper research costs can make vaccines against neglected killers like hepatitis C, tuberculosis and Strep A economically viable for the first time.
Attributed sources:
- Welcome to March 18, 2026 — https://theinnermostloop.substack.com/p/welcome-to-march-18-2026
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.